Holen Sie sich die Stockscreener-App
88.97
4.05%
3.53
Ptc Therapeutics Inc Aktie (PTCT) Neueste Nachrichten
PTCT Maintains Rating by RBC Capital -- Price Target Raised to $85 - GuruFocus
Ptc Therapeutics stock hits all-time high of 87.56 USD By Investing.com - Investing.com South Africa
PTC Therapeutics weighs strategy amid rare disease focus - AD HOC NEWS
RBC Capital Adjusts PTC Therapeutics Price Target to $85 From $82, Maintains Sector Perform Rating - Moomoo
Does Triple Russell 2000 Defensive Index Inclusion Reframe PTC Therapeutics’ Risk Profile And Rare-Disease Story (PTCT)? - simplywall.st
Form 144 PTC THERAPEUTICS For: 6 July By Investing.com - Investing.com Canada
PTCT (NASDAQ) affiliate plans option exercise; director sold 10,522 shares - Stock Titan
All eyes on PTC Therapeutics earnings after brutal Q4 miss - Investing.com
Enterprise value to EBIT forward of PTC Therapeutics, Inc. – NASDAQ:PTCT - TradingView
PTC Therapeutics updates investors on rare disease pipeline as Nasdaq-listed biotech advances progra - AD HOC NEWS
Ptc therapeutics chief technical ops officer sells $693k in stock By Investing.com - Investing.com Australia
Ptc therapeutics chief technical ops officer sells $693k in stock - Investing.com Australia
Form 4 PTC Therapeutics Inc For: 30 June By Investing.com - Investing.com South Africa
Enterprise value to EBITDA forward of PTC Therapeutics, Inc. – NASDAQ:PTCT - TradingView
Price to sales forward of PTC Therapeutics, Inc. – NASDAQ:PTCT - TradingView
Enterprise value to revenue forward of PTC Therapeutics, Inc. – NASDAQ:PTCT - TradingView
PTC Therapeutics, Inc.(NasdaqGS: PTCT) added to Russell 2000 Value-Defensive Index - marketscreener.com
PTC Therapeutics, Inc.(NasdaqGS: PTCT) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Price to earnings forward of PTC Therapeutics, Inc. – FWB:BH3 - TradingView
PTC Therapeutics, Inc.(NasdaqGS: PTCT) added to Russell 2000 Defensive Index - marketscreener.com
Understanding the Setup: (PTCT) and Scalable Risk - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
PTC Therapeutics (PTCT) Launches Sephience After Strong Early Sales And $500 Million Raise - Sahm
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pauwels Eric - Moomoo
Ptc therapeutics chief technical ops officer sells $2.25m in stock - Investing.com South Africa
Form 144 PTC THERAPEUTICS For: 26 June By Investing.com - Investing.com South Africa
Form 4 PTC Therapeutics Inc For: 26 June By Investing.com - Investing.com Australia
PTC Therapeutics (NASDAQ:PTCT) Insider Neil Gregory Almstead Sells 5,323 Shares - MarketBeat
PTC Therapeutics, Inc. Actuals & Estimates (NASDAQ:PTCT) - TradingView
Affiliate sale notice — PTCT (NASDAQ: PTCT) files to sell 8,130 shares - Stock Titan
PTC Therapeutics (NASDAQ:PTCT): What’s Driving the Latest Buzz? - Kalkine Media
PTC Therapeutics Inc (PTCT) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Form 144 PTC THERAPEUTICS For: 25 June By Investing.com - Investing.com Nigeria
PTCT Forecast — Price Target — Prediction for 2027 - TradingView
Huntington's Disease Market Poised for Significant Growth at a CAGR of 14% During the Forecast Period (2026-2036) Amid Advancements in Disease-Modifying Therapies | DelveInsight - Yahoo Finance Singapore
Form 144 PTC THERAPEUTICS For: 24 June By Investing.com - Investing.com South Africa
Form 4 PTC Therapeutics Inc For: 24 June By Investing.com - Investing.com India
Ptc therapeutics chief technical ops officer sells $1.92m in stock By Investing.com - Investing.com Australia
Ptc therapeutics chief technical ops officer sells $1.92m in stock - Investing.com Nigeria
1.21%
3.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):